Predicting the successful peripheral blood stem cell harvesting

Transfusion and Apheresis Science

Volumn 48, Issue 3, 2013, Pages 411-414

  Demiriz, Itir Şirinoǧlu ^a   Bozdaǧ, Sinem Civriz ^a   Tekgündüz, Emre ^a   Uǧur, Bilge ^a   Durgun, Gamze ^a   Koçubaba, Şerife ^a   Altuntaş, Fevzi ^a  

^a ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; GRANULOCYTE COLONY STIMULATING FACTOR; LIPID;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MYELOMA; NONHODGKIN LYMPHOMA; RETROSPECTIVE STUDY; SOLID TUMOR; STEM CELL MOBILIZATION; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; ALKYLATING AGENTS; ANTINEOPLASTIC AGENTS; BLOOD COMPONENT REMOVAL; BLOOD PLATELETS; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84878850992     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.04.028     Document Type: Article

References (36)

1. Ikeda K., Kozuka T., Harada M. Factors for PBPC collection efficiency and collection predictors. Transfus Apher Sci 2004, 31(3):245-259.
2. Demiriz I.S., Tekgunduz E., Altuntas F. What is the most appropriate source for hematopoietic stem cell transplantation? Peripheral stem cell/bone marrow/cord blood 2012, Bone Marrow Research, (article ID: 834040-5 pages; doi: 10.1155/2012/834040).
3. Abhyankar S., DeJarnette S., Aljitawi O., et al. A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor. Bone Marrow Transplant 2012, 47(4):483-487.
4. Tekgündüz E., Altuntaş F., Sivgin S., et al. Plerixafor use in patients with previous mobilization failure: a multicenter experience. Transfus Apher Sci 2012, 47(1):77-80.
5. Sinha S., Gastineau D., Micallef I., et al. Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention. Bone Marrow Transplant 2011, 46(7):943-949.
6. Ozkurt Z.N., Yegin Z.A., Suyani E., et al. Factors affecting stem cell mobilization for autologous hematopoietic stem cell transplantation. J Clin Apher 2010, 25(5):280-286.
7. Bensinger W., Appelbaum F., Rowley S., et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995, 13(10):2547-2555.
8. Ford C.D., Green W., Warenski S., et al. Effect of prior chemotherapy on hematopoietic stem cell mobilization. Bone Marrow Transplant 2004, 33(9):901-905.
9. Akhtar S., Weshi A.E., Rahal M., et al. Factors affecting autologous peripheral blood stem cell collection in patients with relapsed or refractory diffuse large cell lymphoma and Hodgkin lymphoma: a single institution result of 68 patients. Leuk Lymphoma 2008, 49(4):769-778.
10. Kuittinen T., Nousiainen T., Halonen P., et al. Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant 2004, 33(9):907-912.
11. Mendrone A., Arrais C.A., Saboya R., et al. Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients. Transfus Apher Sci 2008, 39(3):187-192.
12. Fruehauf S., Seggewiss R. It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement. Br J Haematol 2003, 122(3):360-375.
13. Mahindra A., Bolwell B., Sobecks R., et al. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. Br J Haematol 2009, 146(3):310-316.
14. Armand P., Kim H.T., Cutler C.S., et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007, 109(10):4586-4588.
15. Altes A., Remacha A.F., Sarda P., et al. Early clinical impact of iron overload in stem cell transplantation. A prospective study. Ann Hematol 2007, 86(6):443-447.
16. Park I.H., Kim Y., Kim J.S., et al. Transfusion-associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignancies. Transfus Med 2008, 18(2):97-103.
17. Jantunen E., Kuittinen T. Blood stem cell mobilization and collection in patients with lymphoproliferative diseases: practical issues. Eur J Haematol 2008, 80(4):287-295.
18. Siena S., Schiavo R., Pedrazzoli P., et al. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 2000, 18(6):1360-1377.
19. Basquiera A.L., Abichain P., Damonte J.C., et al. The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation. J Clin Apher 2006, 21(2):92-95.
20. + cells in multiple myeloma. Ann Hematol 2001, 80(10):592-597.
21. + cells and hemoglobin concentration provides a better optimization of apheresis than the application of a fixed CD34 threshold. Transfusion 2008, 48(6):1133-1137.
22. Jantunen E., Kuittinen T., Nousiainen T. Is chemotherapy scoring useful to predict progenitor cell mobilisation in patients with non-Hodgkin's lymphoma?. Bone Marrow Transplant 2003, 32(6):569-573.
23. Martínez E., Sureda A., Dalmases C.D., et al. Mobilization of peripheral blood progenitor cells by cyclophosphamide and rhGM-CSF in multiple myeloma. Bone Marrow Transplant 1996, 18(1):1-7.
24. Alegre A., Tomás J.F., Martínez-Chamorro C., et al. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs. G-CSF alone. Bone Marrow Transplant 1997, 20(3):211-217.
25. Koumakis G., Vassilomanolakis M., Hatzichristou H., et al. Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies. Bone Marrow Transplant 1996, 18(6):1065-1072.
26. Pusic I., Jiang S.Y., Landua S., et al. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation. Biol Blood Marrow Transplant 2008, 14(9):1045-1056.
27. Corso A., Caberlon S., Pagnucco G., et al. Blood stem cell collections in multiple myeloma: definition of a scoring system. Bone Marrow Transplant 2000, 26(3):283-286.
28. Tricot G., Jagannath S., Vesole D., et al. Peripheralbloodstem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995, 85(2):588-596.
29. Prince H.M., Imrie K., Sutherland D.R., et al. Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections. Br J Haematol 1996, 93(1):142-145.
30. Goldschmidt H., Hegenbart U., Wallmeier M., et al. Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma. Br J Haematol 1997, 98(3):736-744.
31. Demirer T., Buckner C.D., Gooley T., et al. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplant 1996, 17(6):937-941.
32. Drake M., Ranaghan L., Morris T.C., et al. Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system. Br J Haematol 1997, 98(3):745-749.
33. Clark R.E., Brammer C.G. Previous treatment predicts the efficiency of blood progenitor cell mobilization: validation of a chemotherapy scoring system. Bone Marrow Transplant 1998, 22(9):859-863.
34. Tempescul A., Ianotto J.C., Hardy E., et al. Peripheral blood stem cell collection in elderly patients. Ann Hematol 2010, 89(3):317-321.
35. Cottler-Fox M.H., Lapidot T., Petit I., et al. Stem cell mobilization. Hematol Am Soc Hematol Educ Progr 2003, 419-437.
36. + cells. Bone Marrow Transplant 1999, 24(1):25-28.